EMA Approves 12 New Drugs: Breakthroughs in Cholesterol, Psoriasis, and Rare Diseases
European regulators have recommended 12 new medicines for marketing authorization, marking a significant step forward for patients managing complex metabolic conditions, severe dermatological diseases, and rare disorders. The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) issued the positive opinions during its regular monthly meeting, advising expanded treatment options across several … Read more